We synthesize recent mechanistic and clinical evidence showing that NF2 loss establishes a synthetic lethal dependency on FAK signaling, in sharp contrast to the non-essential, compensatory role of FAK in GBM. The gene discussed is PTK2; the disease is glioblastoma.